MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma

MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma

Treatments aimed to reverse the tumor-induced immune tolerance represent a promising approach for advanced hepatocellular carcinoma (HCC). Notwithstanding, primary nonresponse, early, and late disease reactivation still represent major clinical challenges. Here, we focused on microRNAs (miRNAs) acti...

Full description

Bibliographic Details
Main Authors: Laura Gramantieri, Francesca Fornari, Catia Giovannini, Davide Trerè
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Biomolecules
Subjects:
HCC
microRNA
biomarkers
immune system
Online Access:https://www.mdpi.com/2218-273X/12/7/930

Similar Items

Similar Items